CHKA and colorectal carcinoma: Integrating the results of the bioactive compound screening and CRC-specific target genes from the GO annotation and KEGG pathway analyses, we successfully constructed a prediction network of anti-CRC CKI that comprised 82 active compounds, 34 protein targets, and 33 pathways (Figs. 2, 3).